Genetic factors in myocardial infarction - Results from a candidate gene and a genome-wide approach between beta blockers;Genetische einflüsse beim herzinfarkt - Ergebnisse eines kandidatengen- und eines genomweiten ansatzes

Herz

Volumn 27, Issue 7, 2002, Pages 649-661

  Hengstenberg, Christian ^a   Bröckel, Ulrich ^b   Holmer, Stephan ^a   Mayer, Björn ^a   Fischer, Marcus ^a,b   Baessler, Andrea ^a,b   Erdmann, Jeanette ^a   Lieb, Wolfgang ^a   Löwel, Hannelore ^c   Riegger, Günter ^a   Schunkert, Heribert ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Atherosclerosis; Genetics; Myocardial infarction; Myocardial infarction locus

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; GUANINE NUCLEOTIDE BINDING PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STEROID 11BETA MONOOXYGENASE;

ATHEROSCLEROSIS; CAUSE OF DEATH; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; RISK FACTOR; SIBLING; SMOKING;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; ALDOSTERONE SYNTHASE; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; ARTERIOSCLEROSIS; CHI-SQUARE DISTRIBUTION; DATA INTERPRETATION, STATISTICAL; FEMALE; GENETIC SCREENING; GENOTYPE; GERMANY; GTP-BINDING PROTEINS; HEALTH SURVEYS; HUMANS; HYPERTENSION; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHENOTYPE; POLYMORPHISM, GENETIC; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; VENTRICULAR REMODELING;

EID: 18744381541     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-002-2432-1     Document Type: Review

References (43)

1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-42.
2. Muller DW, Topol EJ, Califf RM, Sigmon KN, Gorman L, George BS, et al. Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart 1990;119;224-31.
3. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-62.
4. Humphries SE, Talmud PJ, Cox C, Sutherland W, Mann J. Genetic factors affecting the consistency and magnitude of changes in plasma cholesterol in response to dietary challenge. Q J Med 1996;89:671-80.
5. Hokanson JE. Lipoprotein lipase gene variants and risk of coronary disease: A quantitative analysis of population-based studies. Int J Clin Lab Res 1997;27:24-34.
6. Funke H, Klug J, Assmann G. Hind III RFLP in the lipoprotein lipase gene (LPL). Nucl Acids Res 1987;15:9102.
7. Jemaa R, Tuzet S, Portos C, Betoulle D, Apfelbaum M, Fumeron F. Lipoprotein lipase gene polymorphisms: Associations with hypertriglyceridemia and body mass index in obese people. Int J Obes Relat Metab Disord 1995;19:270-4.
8. Wang XL, McCredie RM, Wilcken DE. Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes. Circulation 1996;93:1339-45.
9. Humphries SE, Nicaud V, Margalef J, Tiret L, Talmud PJ. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: The European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 1998;18:526-34.
10. Peacock RE, Hamsten A, Nilsson EP, Humphries SE. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 1992;97:171-85.
11. Mattu RK, Needham EW, Morgan R, Rees A, Hackshaw AK, Stocks J, et al. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb 1994;14:1090-7.
12. Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H, et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 1998;97:569-75.
13. Brand E, Chatelain N, Mulatero P, Fery I, Curnow K, Jeunemaitre X, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 1998;32:198-204.
14. Schunkert H, Hengstenberg C, Holmer SR, Broeckel U, Luchner A, Muscholl MW, et al. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. Circulation 1999;99:2255-60.
15. Duprez DA, Bauwens FR, De Buyzere ML, De Backer TL, Kaufman JM, van Hoecke J, et al. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension. Am J Cardiol 1993;71:17A-20A.
16. Tamaki S, Iwai N, Tsujita Y, Kinoshita M. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension 1999;33:266-70.
17. Siffert W, Rosskopf D, Moritz A, Wieland T, Kaldenberg-Stasch S, Kettler N, et al. Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest 1995;96:759-66.
18. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998;18:45-8.
19. Schunkert H, Hense HW, Doring A, Riegger GA, Siffert W. Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 1998;32:510-3.
20. Buikema H, Pinto YM, Rooks G, Grandjean JG, Schunkert H, van Gilst WH. The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J 1996;17:787-94.
21. Blackwelder WC, Elston RC. A comparison of sib-pair linkage tests for disease susceptibility loci. Genet Epidemiol 1985;2:85-97.
22. Risch N, Zhang H. Extreme discordant sib pairs for mapping quantitative trait loci in humans. Science 1995;268:1584-9.
23. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: A unified multipoint approach. Am J Hum Genet 1996;58:1347-63.
24. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198-211.
25. Holmer SR, Hengstenberg C, Mayer B, Doring A, Lowel H, Engel S, et al. Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population. Cardiovasc Res 2000;47:806-12.
26. Hengstenberg C, Holmer SR, Mayer B, Lowel H, Engel S, Hense HW, et al. Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction. Hypertension 2000;35:704-9.
27. Hengstenberg C, Schunkert H, Mayer B, Doring A, Lowel H, Hense HW, et al. Association between a polymorphism in the G protein beta3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Cardiovasc Res 2001;49:820-7.
28. Hengstenberg C, Broeckel U, Mayer B, Holmer S, Martin LJ, Comuzzie AG, et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 2002;30:210-4.
29. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease [see comments]. N Engl J Med 1995;332:7o6-11.
30. Danser AH, Schunkert H. Renin-angiotensin system and blood pressure. Circulation 1999;100:e85-6.
31. Anonymous. Freely associating [editorial comment]. Nat Genet 1999;22:1-2.
32. Applebaum DM, Goldberg AP, Pykalisto OJ, Brunzell JD, Hazzard WR. Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase. J Clin Invest 1977;59:601-8.
33. Price TM, O'Brien SN, Welter BH, George R, Anandjiwala J, Kilgore M. Estrogen regulation of adipose tissue lipoprotein lipase-possible mechanism of body fat distribution. Am J Obstet Gynecol 1998;178:101-7.
34. Parini P, Angelin B, Rudling M. Importance of estrogen receptors in hepatic LDL receptor regulation. Arterioscler Thromb Vasc Biol 1997;17:1800-5.
35. Streicher R, Kotzka J, Muller-Wieland D, Krone W. Regulation of the LDL receptor gene expression by hormones. Z Ernährungswiss 1998;37:Suppl 1:85-7.
36. Beige J, Hohenbleicher H, Distler A, Sharma AM. G-protein beta3 subunit C825T variant and ambulatory blood pressure in essential hypertension. Hypertension 1999;33:1049-51.
37. Hegele RA, Harris SB, Hanley AJ, Cao H, Zinman B. G protein beta3 subunit gene variant and blood pressure variation in Canadian Oji-Cree. Hypertension 1998;32:688-92.
38. Benjafield AV, Jeyasingam CL, Nyholt DR, Griffiths LR, Morris BJ. G-protein beta3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension 1998;32:1094-7.
39. Brand E, Herrmann SM, Nicaud V, Ruidavets JB, Evans A, Arveiler D, et al. The 825C/T polymorphism of the G-protein subunit beta3 is not related to hypertension. Hypertension 1999;33:1175-8.
40. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997;15:1579-92.
41. Keavney B, McKenzie C, Parish S, Palmer A, Clark S, Youngman L, et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 2000;355:434-42.
42. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
43. Frank SL, Klisak I, Sparkes RS, Mohandas T, Tomlinson JE, McLean JW, Lawn RM, Lusis AJ. The apolipoprotein(a) gene resides on human chromosome 6q26-27, in close proximity to the homologous gene for plasminogen. Hum Genet 1988;79:352-6.